Avita Medical | Себестоимость

Cost Of Sales Изменить Дата
Adcock Ingram Holdings ZAR 2.91B 127.52M 2023-06
Celltrion KRW 301.94B 54.13B 2023-09
Clinuvel Pharmaceuticals AUD -5056900 2.43M 2023-06
Cochlear AUD 257.3M 31.9M 2023-06
CSL USD 3.15B 174.6M 2023-06
Ecofibre AUD 1.28M 6.12M 2023-06
Kangmei Pharma CNY 974.35M 4.07M 2023-09
Knight Therapeutics CAD 41.32M 11.09M 2023-09
Laboratorios Farma EUR 163.38M 19.38M 2023-06
Malin Corporation EUR 15.4M 0 2020-12
Mayne Pharma AUD 6.83M 86.45M 2023-06
Medical Developments International AUD 6.09M 2.05M 2023-06
Nanosonics AUD 18.15M 944K 2023-06
Opthea USD 85.21K 3.59K 2023-06
Organigram Holdings CAD 45.88M 2.06M 2023-03
Paradigm Biopharmaceuticals AUD 11.47K 4.11K 2023-06
Pharma Mar EUR 3.14M 1.26M 2023-09
Polynovo AUD 2.82M 1.21M 2023-06
Probiotec AUD 74.79M 109.35K 2023-06
PYC Therapeutics AUD 3.1M 2.8M 2020-12
Qiagen NV USD 177.93M 4.77M 2023-09
Ramsay Health Care AUD 1.85B 21.9M 2022-12
ResMed USD 504.67M 50.64M 2023-06
Sartorius EUR 450.8M 25.7M 2023-09
Sino Biopharmaceutical CNY 3.26B 420.59M 2023-06
Telix Pharmaceuticals AUD 79.78M 28.79M 2023-06
Zz Pientze Pharmaceu 1.25B 64.01M 2023-09



Avita Medical Себестоимость - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Apr 2024.